Gene · 2101
Papers2,737
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,737
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Fragmentomic liquid biopsy enables early breast cancer detection, molecular subtyping and lymph node assessment. | Nat Commun | 2026 | 41792156 | PubTator, text mining | PubMed |
| ERRα-ETV5 axis drives PD-L1 upregulation and immune escape in gallbladder cancer. | Cancer Lett | 2026 | 41791643 | PubTator, text mining | PubMed |
| Phosphoenolpyruvate carboxykinase 2 activation of the AMPK-CEBPB axis to enhance glutamine utilization to promote glycolysis and malignant behavior in adenocarcinomas cells under glucose deprivation. | J Cell Commun Signal | 2026 | 41769368 | PubTator, text mining | PubMed |
| Regulation of PERM1 and select target genes in human skeletal muscle following fasting and exercise. | Appl Physiol Nutr Metab | 2026 | 41759080 | PubTator, text mining | PubMed |
| Biological aging across the metabolic dysfunction-associated steatotic liver disease spectrum: A systematic review. | ILIVER | 2026 | 41756167 | PubTator, text mining | PubMed |
| Mitochondria in Renal Ischemia-Reperfusion Injury: From Mechanisms to Therapeutics. | Biomedicines | 2026 | 41751208 | PubTator, text mining | PubMed |
| Nuclear Receptor-Targeted Therapies: Reprogramming Metabolism with TRβ, ERRα, and LXR Modulators. | Biomolecules | 2026 | 41750342 | PubTator, text mining | PubMed |
| Engineering Mitochondrial Biogenesis in iPSC-CMs: CRISPR-Guided Approaches for Advanced Cardiomyocyte Development. | J Cardiovasc Dev Dis | 2026 | 41745325 | PubTator, text mining | PubMed |
| Metabolic Vulnerabilities as a Therapeutic Target in Breast Cancer. | Curr Oncol | 2026 | 41744893 | PubTator, text mining | PubMed |
| Mechanistic insights and therapeutic interventions of mitochondrial quality control in chemotherapy-related cognitive impairment. | Neoplasia | 2026 | 41723889 | PubTator, text mining | PubMed |
| Targeted HDAC8 inhibition with non-hydroxamate [1,2,4]triazolo[4,3-a] quinoline compounds. | Sci Rep | 2026 | 41720839 | PubTator, text mining | PubMed |
| Linking Oxidative Stress to Placental Dysfunction: The Key Role of Mitochondria in Trophoblast Function. | Med Sci (Basel) | 2026 | 41718100 | PubTator, text mining | PubMed |
| ERRα-KDM5C restrains STING enhancer activity to modulate type I interferon signaling in breast cancer progression. | Cell Death Dis | 2026 | 41708589 | PubTator, text mining | PubMed |
| 4-hydroxytamoxifen enhances stemness through the neuropilin-1/estrogen-related receptor alpha pathway to enhance breast cancer cell paclitaxel resistance and metastasis. | J Pharm Pharmacol | 2026 | 41671306 | PubTator, text mining | PubMed |
| Prioritizing rehabilitation in Pakistan's health system: a qualitative policy analysis. | Int J Equity Health | 2026 | 41606596 | PubTator, text mining | PubMed |
| ICG-001 Provides Cardioprotection Against Doxorubicin-Induced Cardiotoxicity and Enhances Cancer Cytotoxicity. | JACC Basic Transl Sci | 2026 | 41579853 | PubTator, text mining | PubMed |
| A titin missense variant drives atrial electrical remodeling and is associated with atrial fibrillation. | Elife | 2026 | 41569083 | PubTator, text mining | PubMed |
| PGC-1β Mediates the Atheroprotective Roles of β-Aminoisobutyric Acid (BAIBA) in Vascular Endothelial Cells. | J Atheroscler Thromb | 2026 | 41565295 | PubTator, text mining | PubMed |
| Otubain deubiquitinases: Multi-layered regulators of cell fate, development, and stress responses across kingdoms. | iScience | 2026 | 41550777 | PubTator, text mining | PubMed |
| Structural Pharmacology of Estrogen-Related Receptors. | ACS Pharmacol Transl Sci | 2026 | 41536281 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2101/papers?page=3